Tag: veterinary molecular diagnostics industry size

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Veterinary Molecular Diagnostics Market Growth Potential: How Will Market Size Shift Through 2030?

The veterinary molecular diagnostics market has seen significant expansion over recent years. Its valuation is projected to rise from $0.7 billion in 2025 to $0.77 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.9%. This historical growth can be linked to several factors including the increasing incidence of infectious and genetic animal diseases, breakthroughs in molecular biology technology, the growing populations of companion and livestock animals, elevated veterinary awareness and training initiatives, and the adoption of conventional molecular diagnostic kits.

The veterinary molecular diagnostics market is anticipated to experience substantial expansion over the coming years, with its valuation projected to reach $1.11 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.6%. This anticipated growth during the forecast period stems from factors such as increasing demand for swift and precise molecular diagnostics, the widespread adoption of NGS and high-throughput platforms, the broadening of veterinary genomics services, the incorporation of AI-driven diagnostic analysis, and an increasing focus on preventive veterinary care facilitated by molecular testing. Key developments expected in the forecast period encompass the proliferation of PCR and RT-PCR-based diagnostics, the rising uptake of next-generation sequencing (NGS) within veterinary medicine, the creation of multiplex diagnostic kits designed for infectious diseases, the seamless incorporation of molecular diagnostics into standard veterinary care, and the emergence of automated, high-throughput molecular testing solutions.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=20687&type=smp&name=Veterinary%20Molecular%20Diagnostics%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary Molecular Diagnostics Market Growth Backed By Core Demand Fundamentals

The significant occurrence of zoonotic diseases is projected to drive the future growth of the veterinary molecular diagnostics market. These infectious diseases are transferred between animals and humans, and their causes can include bacteria, viruses, parasites, or fungi. Common examples of zoonotic diseases are rabies, Lyme disease, salmonellosis, and toxoplasmosis. The widespread nature of zoonotic diseases is influenced by factors like deforestation, wildlife exploitation, intensive animal farming, biodiversity loss, and human mobility. Veterinary molecular diagnostics aid in the early detection of these diseases in animals, which helps prevent their spread to humans. They also improve disease management by enabling the quick and accurate identification of pathogens. For instance, in December 2025, the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, stated that in 2024, the reported human cases of key zoonotic diseases such as campylobacteriosis (168,396 cases) and salmonellosis (79,703 cases) continued to rise, indicating a notable ongoing prevalence of zoonoses in Europe. Therefore, the high prevalence of zoonotic diseases is a key driver for the veterinary molecular diagnostics market.

Veterinary Molecular Diagnostics Market Segment Analysis: What Are The Core Market Categories?

The veterinary molecular diagnostics market covered in this report is segmented –

1) By Product: Kits And Reagents, Instruments

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Infectious Diseases, Genetic Diseases, Other Applications

4) By End-User: Diagnostic Laboratories, Veterinary Clinics, Veterinary Hospitals, Other End-Users

Subsegments:

1) By Kits And Reagents: Polymerase Chain Reaction (PCR) Kits, Reverse Transcription PCR (RT-PCR) Kits, Real-Time PCR Kits, Nucleic Acid Extraction Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Hybridization Kits, Reagents For Next-Generation Sequencing (NGS)

2) By Instruments: PCR Machines (Thermal Cyclers), Real-Time PCR Machines, Nucleic Acid Analyzers, Gel Electrophoresis Equipment, DNA Sequencers, Automated Liquid Handling Systems, Molecular Imaging Systems

Veterinary Molecular Diagnostics Market Growth Trends Reshaping The Competitive Landscape

Major companies operating in the veterinary molecular diagnostics market are concentrating on automation and scalability in diagnostic technologies, such as high-volume testing machines, to improve diagnostic accuracy, increase testing efficiency, and enable faster detection of diseases in animals. High-volume testing machines are advanced diagnostic devices designed to process large quantities of samples efficiently, enabling rapid and accurate analysis in laboratories or clinical settings, particularly useful for large-scale testing. For instance, in June 2023, Iowa State University’s Veterinary Diagnostic Laboratory (VDL), a US-based university, introduced SmartChip, a cutting-edge molecular diagnostic testing device equipped with quantitative polymerase chain reaction (qPCR) testing technology. This innovative device can accommodate more than 5,000 samples on a plate no bigger than a postage stamp. It greatly increases its testing capacity when paired with a 384-sample system equipped with automated handling features. The SmartChip testing utilizes microfluidic technology to identify targets of interest in samples, employing a volume 100 times smaller than that used by the VDL’s standard 96-well machines.

Veterinary Molecular Diagnostics Market Competitive Overview And Top Companies

Major companies operating in the veterinary molecular diagnostics market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Zoetis Inc., Illumina Inc., PerkinElmer Inc., bioMérieux S.A., IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., LGC Group Ltd., Neogen Corporation, Abcam plc, Eiken Chemical Co. Ltd., Bioneer Corporation, INDICAL BIOSCIENCE GmbH, Biochek B.V., Ring Biotechnology Co. Ltd., Ingenetix GmbH, MiDOG Animal Diagnostics LLC, Biolab S.r.l., Bionote USA Inc.

View The Full Veterinary Molecular Diagnostics Market Report:

https://thebusinessresearchcompany.com/report/veterinary-molecular-diagnostics-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Veterinary Molecular Diagnostics Market Top Region: Where Does Most Revenue Come From?

North America was the largest region in the Veterinary Molecular Diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

#Veterinary Molecular Diagnostics Market Growth Potential: How Will Market Size Shift Through 2030?#_x000D_

The veterinary molecular diagnostics market has seen significant expansion over recent years. Its valuation is projected to rise from $0.7 billion in 2025 to $0.77 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.9%. This historical growth can be linked to several factors including the increasing incidence of infectious and genetic animal diseases, breakthroughs in molecular biology technology, the growing populations of companion and livestock animals, elevated veterinary awareness and training initiatives, and the adoption of conventional molecular diagnostic kits._x000D_

_x000D_

The veterinary molecular diagnostics market is anticipated to experience substantial expansion over the coming years, with its valuation projected to reach $1.11 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.6%. This anticipated growth during the forecast period stems from factors such as increasing demand for swift and precise molecular diagnostics, the widespread adoption of NGS and high-throughput platforms, the broadening of veterinary genomics services, the incorporation of AI-driven diagnostic analysis, and an increasing focus on preventive veterinary care facilitated by molecular testing. Key developments expected in the forecast period encompass the proliferation of PCR and RT-PCR-based diagnostics, the rising uptake of next-generation sequencing (NGS) within veterinary medicine, the creation of multiplex diagnostic kits designed for infectious diseases, the seamless incorporation of molecular diagnostics into standard veterinary care, and the emergence of automated, high-throughput molecular testing solutions._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=20687&type=smp&name=Veterinary%20Molecular%20Diagnostics%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Veterinary Molecular Diagnostics Market Growth Backed By Core Demand Fundamentals#_x000D_

The significant occurrence of zoonotic diseases is projected to drive the future growth of the veterinary molecular diagnostics market. These infectious diseases are transferred between animals and humans, and their causes can include bacteria, viruses, parasites, or fungi. Common examples of zoonotic diseases are rabies, Lyme disease, salmonellosis, and toxoplasmosis. The widespread nature of zoonotic diseases is influenced by factors like deforestation, wildlife exploitation, intensive animal farming, biodiversity loss, and human mobility. Veterinary molecular diagnostics aid in the early detection of these diseases in animals, which helps prevent their spread to humans. They also improve disease management by enabling the quick and accurate identification of pathogens. For instance, in December 2025, the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, stated that in 2024, the reported human cases of key zoonotic diseases such as campylobacteriosis (168,396 cases) and salmonellosis (79,703 cases) continued to rise, indicating a notable ongoing prevalence of zoonoses in Europe. Therefore, the high prevalence of zoonotic diseases is a key driver for the veterinary molecular diagnostics market._x000D_

_x000D_

#Veterinary Molecular Diagnostics Market Segment Analysis: What Are The Core Market Categories?#_x000D_

The veterinary molecular diagnostics market covered in this report is segmented – _x000D_

_x000D_

1) By Product: Kits And Reagents, Instruments_x000D_

2) By Animal Type: Companion Animals, Livestock Animals_x000D_

3) By Application: Infectious Diseases, Genetic Diseases, Other Applications_x000D_

4) By End-User: Diagnostic Laboratories, Veterinary Clinics, Veterinary Hospitals, Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Kits And Reagents: Polymerase Chain Reaction (PCR) Kits, Reverse Transcription PCR (RT-PCR) Kits, Real-Time PCR Kits, Nucleic Acid Extraction Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Hybridization Kits, Reagents For Next-Generation Sequencing (NGS) _x000D_

2) By Instruments: PCR Machines (Thermal Cyclers), Real-Time PCR Machines, Nucleic Acid Analyzers, Gel Electrophoresis Equipment, DNA Sequencers, Automated Liquid Handling Systems, Molecular Imaging Systems_x000D_

_x000D_

#Veterinary Molecular Diagnostics Market Growth Trends Reshaping The Competitive Landscape#_x000D_

Major companies operating in the veterinary molecular diagnostics market are concentrating on automation and scalability in diagnostic technologies, such as high-volume testing machines, to improve diagnostic accuracy, increase testing efficiency, and enable faster detection of diseases in animals. High-volume testing machines are advanced diagnostic devices designed to process large quantities of samples efficiently, enabling rapid and accurate analysis in laboratories or clinical settings, particularly useful for large-scale testing. For instance, in June 2023, Iowa State University’s Veterinary Diagnostic Laboratory (VDL), a US-based university, introduced SmartChip, a cutting-edge molecular diagnostic testing device equipped with quantitative polymerase chain reaction (qPCR) testing technology. This innovative device can accommodate more than 5,000 samples on a plate no bigger than a postage stamp. It greatly increases its testing capacity when paired with a 384-sample system equipped with automated handling features. The SmartChip testing utilizes microfluidic technology to identify targets of interest in samples, employing a volume 100 times smaller than that used by the VDL’s standard 96-well machines._x000D_

_x000D_

#Veterinary Molecular Diagnostics Market Competitive Overview And Top Companies#_x000D_

Major companies operating in the veterinary molecular diagnostics market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Zoetis Inc., Illumina Inc., PerkinElmer Inc., bioMérieux S.A., IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., LGC Group Ltd., Neogen Corporation, Abcam plc, Eiken Chemical Co. Ltd., Bioneer Corporation, INDICAL BIOSCIENCE GmbH, Biochek B.V., Ring Biotechnology Co. Ltd., Ingenetix GmbH, MiDOG Animal Diagnostics LLC, Biolab S.r.l., Bionote USA Inc. _x000D_

_x000D_

#View The Full Veterinary Molecular Diagnostics Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/veterinary-molecular-diagnostics-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Veterinary Molecular Diagnostics Market Top Region: Where Does Most Revenue Come From?#_x000D_

North America was the largest region in the Veterinary Molecular Diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Is The Market Value Of The Veterinary Molecular Diagnostics Market Projected To Expand During 2026–2030?

The veterinary molecular diagnostics market has shown substantial expansion in recent years. Its valuation is set to increase from $0.7 billion in 2025 to $0.77 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.9%. This past growth can be attributed to the rising incidence of infectious and genetic animal diseases, advancements in molecular biology technology, an increase in companion and livestock animal populations, heightened veterinary awareness and training, and the widespread use of conventional molecular diagnostic kits.

The veterinary molecular diagnostics market size is projected to experience substantial expansion over the next few years. It is anticipated to grow to $1.11 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 9.6%. This expected growth during the forecast period can be attributed to the escalating demand for swift and precise molecular diagnostics, the integration of NGS and high-throughput platforms, the widening scope of veterinary genomics services, the incorporation of AI-driven diagnostic analysis, and an increasing focus on preventive veterinary care through molecular testing. Prominent trends for the forecast period include the broader application of PCR and RT-PCR-based diagnostics, the rising adoption of next-generation sequencing (NGS) in veterinary medicine, the development of multiplex diagnostic kits for infectious diseases, the integration of molecular diagnostics into routine veterinary care, and the availability of automation and high-throughput molecular testing solutions.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20687&type=smp

Which Major Factors Are Contributing To The Development Of The Veterinary Molecular Diagnostics Market?

The high prevalence of zoonotic diseases is expected to propel the growth of the veterinary molecular diagnostics market going forward. Zoonotic diseases are infectious diseases that are transmitted between animals and humans. These diseases can be caused by bacteria, viruses, parasites, or fungi. Common zoonotic diseases include rabies, Lyme disease, salmonellosis, toxoplasmosis, and more. The prevalence of zoonotic diseases is influenced by deforestation, wildlife exploitation, intensive animal farming, biodiversity loss, and human mobility. Veterinary molecular diagnostics help detect zoonotic diseases early in animals, preventing their spread to humans. They also improve disease management by enabling rapid, accurate identification of pathogens. For instance, in December 2025, according to the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, in 2024, the number of reported human cases of key zoonotic diseases such as campylobacteriosis (168,396 cases) and salmonellosis (79,703 cases) continued to increase, reflecting a significant ongoing prevalence of zoonoses in Europe . Therefore, the high prevalence of zoonotic diseases is driving the veterinary molecular diagnostics market.

How Is Segment Classification Applied In The Veterinary Molecular Diagnostics Market?

The veterinary molecular diagnostics market covered in this report is segmented –

1) By Product: Kits And Reagents, Instruments

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Infectious Diseases, Genetic Diseases, Other Applications

4) By End-User: Diagnostic Laboratories, Veterinary Clinics, Veterinary Hospitals, Other End-Users

Subsegments:

1) By Kits And Reagents: Polymerase Chain Reaction (PCR) Kits, Reverse Transcription PCR (RT-PCR) Kits, Real-Time PCR Kits, Nucleic Acid Extraction Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Hybridization Kits, Reagents For Next-Generation Sequencing (NGS)

2) By Instruments: PCR Machines (Thermal Cyclers), Real-Time PCR Machines, Nucleic Acid Analyzers, Gel Electrophoresis Equipment, DNA Sequencers, Automated Liquid Handling Systems, Molecular Imaging Systems

Which Trends Are Supporting The Evolution Of The Veterinary Molecular Diagnostics Market?

Major companies operating in the veterinary molecular diagnostics market are focusing on automation and scalability in diagnostic technologies, such as high-volume testing machines, to improve diagnostic accuracy, increase testing efficiency, and enable faster detection of diseases in animals. High-volume testing machines are advanced diagnostic devices designed to process large quantities of samples efficiently, enabling rapid and accurate analysis in laboratories or clinical settings, particularly useful for large-scale testing. For instance, in June 2023, Iowa State University’s Veterinary Diagnostic Laboratory (VDL), a US-based university, introduced SmartChip, a cutting-edge molecular diagnostic testing device equipped with quantitative polymerase chain reaction (qPCR) testing technology. This innovative device can accommodate more than 5,000 samples on a plate no bigger than a postage stamp. It greatly increases its testing capacity when paired with a 384-sample system equipped with automated handling features. The SmartChip testing utilizes microfluidic technology to identify targets of interest in samples, employing a volume 100 times smaller than that used by the VDL’s standard 96-well machines.

Who Are The Major Companies Operating In The Veterinary Molecular Diagnostics Market?

North America was the largest region in the Veterinary Molecular Diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access The Complete Veterinary Molecular Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/veterinary-molecular-diagnostics-global-market-report

Which Region Holds The Largest Share In The Veterinary Molecular Diagnostics Market?

North America was the largest region in the Veterinary Molecular Diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Veterinary Molecular Diagnostics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=20687&type=smp

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Autoimmune Gastrointestinal Dysmotility Market During The Forecast Period 2026–2030?

The veterinary molecular diagnostics market has demonstrated strong growth over recent years. It is projected to expand from $0.7 billion in 2025 to $0.77 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.9%. This historical expansion is attributable to various factors, including the increasing prevalence of infectious and genetic animal diseases, advancements in molecular biology technology, the rising populations of companion and livestock animals, enhanced veterinary awareness and training, and the widespread adoption of conventional molecular diagnostic kits.

The veterinary molecular diagnostics market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $1.11 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.6%. Factors contributing to this growth during the projected period include an increasing need for swift and precise molecular diagnostics, the uptake of ngs and high-throughput platforms, the broadening of veterinary genomics services, the incorporation of ai-driven diagnostic analysis, and an increasing focus on preventative veterinary care utilizing molecular testing. Key trends anticipated in the forecast period encompass the broadening use of pcr and rt-pcr-based diagnostics, the rising embrace of next-generation sequencing (ngs) in veterinary medicine, the creation of multiplex diagnostic kits for infectious diseases, the incorporation of molecular diagnostics into standard veterinary practices, and the development of automated and high-throughput molecular testing solutions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20687&type=smp

Which Major Factors Are Driving The Expansion Of The Autoimmune Gastrointestinal Dysmotility Market?

The widespread incidence of zoonotic diseases is projected to drive future growth in the veterinary molecular diagnostics market. Zoonotic diseases are infectious illnesses that can be transmitted between animals and humans. These conditions may be caused by bacteria, viruses, parasites, or fungi. Examples of common zoonoses include rabies, Lyme disease, salmonellosis, toxoplasmosis, and others. The prevalence of zoonotic diseases is influenced by factors such as deforestation, wildlife exploitation, intensive animal farming, biodiversity loss, and human mobility. Veterinary molecular diagnostics aid in the early detection of zoonotic diseases in animals, thereby preventing their spread to humans, and also improve disease management by enabling rapid, accurate identification of pathogens. For instance, in December 2025, according to the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, in 2024, the number of reported human cases of key zoonotic diseases such as campylobacteriosis (168,396 cases) and salmonellosis (79,703 cases) continued to increase, reflecting a significant ongoing prevalence of zoonoses in Europe. Therefore, the high prevalence of zoonotic diseases is a key driver for the veterinary molecular diagnostics market.

What Market Segments Are Evaluated Within The Autoimmune Gastrointestinal Dysmotility Market?

The veterinary molecular diagnostics market covered in this report is segmented –

1) By Product: Kits And Reagents, Instruments

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Infectious Diseases, Genetic Diseases, Other Applications

4) By End-User: Diagnostic Laboratories, Veterinary Clinics, Veterinary Hospitals, Other End-Users

Subsegments:

1) By Kits And Reagents: Polymerase Chain Reaction (PCR) Kits, Reverse Transcription PCR (RT-PCR) Kits, Real-Time PCR Kits, Nucleic Acid Extraction Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Hybridization Kits, Reagents For Next-Generation Sequencing (NGS)

2) By Instruments: PCR Machines (Thermal Cyclers), Real-Time PCR Machines, Nucleic Acid Analyzers, Gel Electrophoresis Equipment, DNA Sequencers, Automated Liquid Handling Systems, Molecular Imaging Systems

What Industry Trends Are Redefining The Veterinary Molecular Diagnostics Market?

Major companies operating in the veterinary molecular diagnostics market are placing a strong emphasis on automation and scalability within diagnostic technologies, such as high-volume testing machines, to enhance diagnostic accuracy, improve testing efficiency, and enable quicker detection of diseases in animals. High-volume testing machines are advanced diagnostic instruments designed to efficiently process large quantities of samples, facilitating rapid and accurate analysis in laboratory or clinical settings, which is particularly beneficial for large-scale testing. For instance, in June 2023, Iowa State University’s Veterinary Diagnostic Laboratory (VDL), a US-based university, launched SmartChip, a cutting-edge molecular diagnostic testing device featuring quantitative polymerase chain reaction (qPCR) testing technology. This innovative device can accommodate more than 5,000 samples on a plate no bigger than a postage stamp, and it considerably increases its testing capacity when integrated with a 384-sample system equipped with automated handling features. The SmartChip testing utilizes microfluidic technology to identify targets of interest in samples, employing a volume 100 times smaller than that used by the VDL’s standard 96-well machines.

Who Are The Top Market Participants Influencing The Autoimmune Gastrointestinal Dysmotility Market?

Major companies operating in the veterinary molecular diagnostics market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Zoetis Inc., Illumina Inc., PerkinElmer Inc., bioMérieux S.A., IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., LGC Group Ltd., Neogen Corporation, Abcam plc, Eiken Chemical Co. Ltd., Bioneer Corporation, INDICAL BIOSCIENCE GmbH, Biochek B.V., Ring Biotechnology Co. Ltd., Ingenetix GmbH, MiDOG Animal Diagnostics LLC, Biolab S.r.l., Bionote USA Inc.

Read the full veterinary molecular diagnostics market report here:

https://www.thebusinessresearchcompany.com/report/veterinary-molecular-diagnostics-global-market-report

Which Region Currently Holds The Largest Share Of The Autoimmune Gastrointestinal Dysmotility Market?

North America was the largest region in the Veterinary Molecular Diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Autoimmune Gastrointestinal Dysmotility Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20687&type=smp

Browse Through More Reports Similar to the Global Veterinary Molecular Diagnostics Market 2026, By The Business Research Company

Veterinary Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Veterinary Parasiticides Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-parasiticides-global-market-report

Veterinary Antibiotics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Autoimmune Gastrointestinal Dysmotility Market During The Forecast Period 2026–2030?

The veterinary molecular diagnostics market has demonstrated strong growth over recent years. It is projected to expand from $0.7 billion in 2025 to $0.77 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.9%. This historical expansion is attributable to various factors, including the increasing prevalence of infectious and genetic animal diseases, advancements in molecular biology technology, the rising populations of companion and livestock animals, enhanced veterinary awareness and training, and the widespread adoption of conventional molecular diagnostic kits.

The veterinary molecular diagnostics market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $1.11 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.6%. Factors contributing to this growth during the projected period include an increasing need for swift and precise molecular diagnostics, the uptake of ngs and high-throughput platforms, the broadening of veterinary genomics services, the incorporation of ai-driven diagnostic analysis, and an increasing focus on preventative veterinary care utilizing molecular testing. Key trends anticipated in the forecast period encompass the broadening use of pcr and rt-pcr-based diagnostics, the rising embrace of next-generation sequencing (ngs) in veterinary medicine, the creation of multiplex diagnostic kits for infectious diseases, the incorporation of molecular diagnostics into standard veterinary practices, and the development of automated and high-throughput molecular testing solutions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20687&type=smp

Which Major Factors Are Driving The Expansion Of The Autoimmune Gastrointestinal Dysmotility Market?

The widespread incidence of zoonotic diseases is projected to drive future growth in the veterinary molecular diagnostics market. Zoonotic diseases are infectious illnesses that can be transmitted between animals and humans. These conditions may be caused by bacteria, viruses, parasites, or fungi. Examples of common zoonoses include rabies, Lyme disease, salmonellosis, toxoplasmosis, and others. The prevalence of zoonotic diseases is influenced by factors such as deforestation, wildlife exploitation, intensive animal farming, biodiversity loss, and human mobility. Veterinary molecular diagnostics aid in the early detection of zoonotic diseases in animals, thereby preventing their spread to humans, and also improve disease management by enabling rapid, accurate identification of pathogens. For instance, in December 2025, according to the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, in 2024, the number of reported human cases of key zoonotic diseases such as campylobacteriosis (168,396 cases) and salmonellosis (79,703 cases) continued to increase, reflecting a significant ongoing prevalence of zoonoses in Europe. Therefore, the high prevalence of zoonotic diseases is a key driver for the veterinary molecular diagnostics market.

What Market Segments Are Evaluated Within The Autoimmune Gastrointestinal Dysmotility Market?

The veterinary molecular diagnostics market covered in this report is segmented –

1) By Product: Kits And Reagents, Instruments

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Infectious Diseases, Genetic Diseases, Other Applications

4) By End-User: Diagnostic Laboratories, Veterinary Clinics, Veterinary Hospitals, Other End-Users

Subsegments:

1) By Kits And Reagents: Polymerase Chain Reaction (PCR) Kits, Reverse Transcription PCR (RT-PCR) Kits, Real-Time PCR Kits, Nucleic Acid Extraction Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Hybridization Kits, Reagents For Next-Generation Sequencing (NGS)

2) By Instruments: PCR Machines (Thermal Cyclers), Real-Time PCR Machines, Nucleic Acid Analyzers, Gel Electrophoresis Equipment, DNA Sequencers, Automated Liquid Handling Systems, Molecular Imaging Systems

What Industry Trends Are Redefining The Veterinary Molecular Diagnostics Market?

Major companies operating in the veterinary molecular diagnostics market are placing a strong emphasis on automation and scalability within diagnostic technologies, such as high-volume testing machines, to enhance diagnostic accuracy, improve testing efficiency, and enable quicker detection of diseases in animals. High-volume testing machines are advanced diagnostic instruments designed to efficiently process large quantities of samples, facilitating rapid and accurate analysis in laboratory or clinical settings, which is particularly beneficial for large-scale testing. For instance, in June 2023, Iowa State University’s Veterinary Diagnostic Laboratory (VDL), a US-based university, launched SmartChip, a cutting-edge molecular diagnostic testing device featuring quantitative polymerase chain reaction (qPCR) testing technology. This innovative device can accommodate more than 5,000 samples on a plate no bigger than a postage stamp, and it considerably increases its testing capacity when integrated with a 384-sample system equipped with automated handling features. The SmartChip testing utilizes microfluidic technology to identify targets of interest in samples, employing a volume 100 times smaller than that used by the VDL’s standard 96-well machines.

Who Are The Top Market Participants Influencing The Autoimmune Gastrointestinal Dysmotility Market?

Major companies operating in the veterinary molecular diagnostics market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Zoetis Inc., Illumina Inc., PerkinElmer Inc., bioMérieux S.A., IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., LGC Group Ltd., Neogen Corporation, Abcam plc, Eiken Chemical Co. Ltd., Bioneer Corporation, INDICAL BIOSCIENCE GmbH, Biochek B.V., Ring Biotechnology Co. Ltd., Ingenetix GmbH, MiDOG Animal Diagnostics LLC, Biolab S.r.l., Bionote USA Inc.

Read the full veterinary molecular diagnostics market report here:

https://www.thebusinessresearchcompany.com/report/veterinary-molecular-diagnostics-global-market-report

Which Region Currently Holds The Largest Share Of The Autoimmune Gastrointestinal Dysmotility Market?

North America was the largest region in the Veterinary Molecular Diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Autoimmune Gastrointestinal Dysmotility Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20687&type=smp

Browse Through More Reports Similar to the Global Veterinary Molecular Diagnostics Market 2026, By The Business Research Company

Veterinary Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Veterinary Parasiticides Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-parasiticides-global-market-report

Veterinary Antibiotics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the inorganic ceramic membrane market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Veterinary Molecular Diagnostics Market be in 2030 compared with 2026?

The veterinary molecular diagnostics market size has experienced robust growth in recent years. It is forecast to increase from $0.7 billion in 2025 to $0.77 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.9%. This expansion in the past can be linked to the growing incidence of infectious and genetic animal diseases, ongoing technological advancements in molecular biology, the increase in companion and livestock animal populations, enhanced veterinary awareness and training initiatives, and the widespread adoption of conventional molecular diagnostic kits.

The veterinary molecular diagnostics market size is projected to experience robust expansion in the coming years. It is anticipated to grow to $1.11 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 9.6%. The expansion during this forecast period can be attributed to a rising need for rapid and accurate molecular diagnostics, the adoption of NGS and high-throughput platforms, the broadening of veterinary genomics services, the integration of AI-driven diagnostic analysis, and an increasing emphasis on preventive veterinary care through molecular testing. Significant trends expected during the forecast period include the greater use of PCR and RT-PCR-based diagnostics, the growing embrace of next-generation sequencing (NGS) in veterinary medicine, the development of multiplex diagnostic kits for infectious diseases, the incorporation of molecular diagnostics into routine veterinary care, and the availability of automation and high-throughput molecular testing solutions.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20687&type=smp

What Drivers Are Guiding Growth Patterns In The Veterinary Molecular Diagnostics Market?

A significant incidence of zoonotic diseases is anticipated to drive forward the expansion of the veterinary molecular diagnostics market. These are infectious illnesses communicable from animals to humans, with origins that can include bacteria, viruses, parasites, or fungi. Examples of prevalent zoonotic conditions encompass rabies, Lyme disease, salmonellosis, toxoplasmosis, among others. Factors affecting the spread of zoonotic diseases involve deforestation, wildlife exploitation, intensive animal farming practices, biodiversity reduction, and human population movement. Early detection of zoonotic diseases in animals through veterinary molecular diagnostics aids in preventing human transmission. Furthermore, these diagnostics enhance disease management through prompt and precise pathogen identification. For example, data from December 2025, provided by the European Centre for Disease Prevention and Control (ECDC), a government agency based in Sweden, indicated that in 2024, reported human cases of significant zoonotic diseases, specifically campylobacteriosis (168,396 cases) and salmonellosis (79,703 cases), persistently rose, underscoring a considerable and continuing occurrence of zoonoses across Europe. Consequently, the widespread occurrence of zoonotic diseases is propelling the veterinary molecular diagnostics market.

How Is The Veterinary Molecular Diagnostics Market Divided Into Segments?

The veterinary molecular diagnostics market covered in this report is segmented –

1) By Product: Kits And Reagents, Instruments

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Infectious Diseases, Genetic Diseases, Other Applications

4) By End-User: Diagnostic Laboratories, Veterinary Clinics, Veterinary Hospitals, Other End-Users

Subsegments:

1) By Kits And Reagents: Polymerase Chain Reaction (PCR) Kits, Reverse Transcription PCR (RT-PCR) Kits, Real-Time PCR Kits, Nucleic Acid Extraction Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Hybridization Kits, Reagents For Next-Generation Sequencing (NGS)

2) By Instruments: PCR Machines (Thermal Cyclers), Real-Time PCR Machines, Nucleic Acid Analyzers, Gel Electrophoresis Equipment, DNA Sequencers, Automated Liquid Handling Systems, Molecular Imaging Systems

Which Trends Are Influencing The Development Of The Veterinary Molecular Diagnostics Market?

Leading firms within the veterinary molecular diagnostics market are prioritizing automation and scalability in their diagnostic technologies, including high-volume testing machines, with the goal of enhancing diagnostic accuracy, boosting testing efficiency, and accelerating disease detection in animals. These high-volume testing machines represent sophisticated diagnostic equipment, engineered to efficiently handle substantial numbers of samples, thereby facilitating swift and precise analysis in laboratory or clinical environments, proving especially valuable for extensive testing operations. An example of this is seen in June 2023, when Iowa State University’s Veterinary Diagnostic Laboratory (VDL), a US-based university, launched SmartChip, a state-of-the-art molecular diagnostic testing device featuring quantitative polymerase chain reaction (qPCR) testing technology. This novel instrument is capable of processing over 5,000 samples on a single plate, which is no larger than a postage stamp. Its testing capacity is significantly amplified when integrated with a 384-sample system that includes automated handling capabilities. SmartChip testing employs microfluidic technology to pinpoint specific targets within samples, using a volume 100 times smaller than the volume utilized by the VDL’s standard 96-well machines.

Which Key Players Are Driving Competition In The Veterinary Molecular Diagnostics Market?

Major companies operating in the veterinary molecular diagnostics market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Zoetis Inc., Illumina Inc., PerkinElmer Inc., bioMérieux S.A., IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., LGC Group Ltd., Neogen Corporation, Abcam plc, Eiken Chemical Co. Ltd., Bioneer Corporation, INDICAL BIOSCIENCE GmbH, Biochek B.V., Ring Biotechnology Co. Ltd., Ingenetix GmbH, MiDOG Animal Diagnostics LLC, Biolab S.r.l., Bionote USA Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/veterinary-molecular-diagnostics-global-market-report

Which Region Is Projected To Lead The Veterinary Molecular Diagnostics Market During The Forecast Period?

North America was the largest region in the Veterinary Molecular Diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Veterinary Molecular Diagnostics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20687&type=smp

Browse Through More Reports Similar to the Global Veterinary Molecular Diagnostics Market 2026, By The Business Research Company

Veterinary Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Veterinary Parasiticides Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-parasiticides-global-market-report

Veterinary Antibiotics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Discover trends, market shifts, and competitive outlooks for the veterinary molecular diagnostics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Projected Market Size and Growth Rates for the Veterinary Molecular Diagnostics Market From 2025 To 2029?

Over the last few years, the veterinary molecular diagnostics market has seen a substantial burst of growth. The market, which stood at $0.63 billion in 2024, is projected to reach $0.7 billion by 2025, signifying a compound annual growth rate (CAGR) of 10.1%. This surge during the historical period can be linked to several factors including the widespread nature of zoonotic and food-related illnesses, the growing acceptance of various testing panels, increasing consolidation in the veterinary diagnostics sector, higher expenditure on animal health and a burgeoning demand for food derived from animals.

There is a robust expansion projected for the veterinary molecular diagnostics market in the forthcoming years, with an expected increase to $1.01 billion by 2029, translating to a compound annual growth rate (CAGR) of 9.7%. Several significant factors contributing to this growth in the projected timeframe can be ascribed to the uptrend in companion animal ownership, increasing participation in pet insurance, rising pet populace, more expenditure on animal healthcare, and growing necessity for animal diagnostic examinations. Foreseen trends in the projected period encompass breakthroughs in veterinary molecular diagnostic methods, enhanced laboratory equipment, and technological advances in areas like PCR, next-generation sequencing (NGS), and microarray technologies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20687&type=smp

Which Factors and External Forces Are Driving Demand in the Veterinary Molecular Diagnostics Market?

The rise in zoonotic diseases is anticipated to spur the expansion of the veterinary molecular diagnostics market. Zoonotic diseases, infectious diseases transferred between animals and humans, are facilitated by bacteria, viruses, parasites, or fungi. Frequent ones include Lyme disease, rabies, salmonellosis, toxoplasmosis, among others. Factors impacting zoonotic diseases prevalence comprise deforestation, biodiversity reduction, intensive animal farming, human mobility, and wildlife exploitation. Veterinary molecular diagnostics contribute significantly to the early detection of such diseases in animals, impeding them from affecting humans. Plus, they facilitate effective disease management through quick and accurate pathogens identification. An example is a report issued by the United Kingdom Government, which reports that the total confirmed Lyme disease cases documented in England during the fourth quarter of 2023 amounted to 335, an escalation from 273 cases noted the same period of the previous year. Consequently, the surge in zoonotic diseases prevalence is a key driver for the veterinary molecular diagnostics market.

Which Segments in the Veterinary Molecular Diagnostics Offer the Most Growth?

The veterinary molecular diagnostics market covered in this report is segmented –

1) By Product: Kits And Reagents, Instrument

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Infectious Diseases, Genetic Diseases, Other Applications

4) By End-User: Diagnostic Laboratories, Veterinary Clinics, Veterinary Hospitals, Other End-Users

Subsegments:

1) Kits and Reagents: Polymerase Chain Reaction (PCR) Kits, Reverse Transcription PCR (RT-PCR) Kits, Real-Time PCR Kits, Nucleic Acid Extraction Kits, Enzyme-linked Immunosorbent Assay (ELISA) Kits, Hybridization Kits, Reagents for Next-Generation Sequencing (NGS)

2) Instruments: PCR Machines (Thermal Cyclers), Real-Time PCR Machines, Nucleic Acid Analyzers, Gel Electrophoresis Equipment, DNA Sequencers, Automated Liquid Handling Systems, Molecular Imaging Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20687&type=smp

What Are the Fastest-Growing Geographies in the Veterinary Molecular Diagnostics Market?

North America was the largest region in the Veterinary Molecular Diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Trends Are Shaping the Future of the Veterinary Molecular Diagnostics Market?

Top firms functioning within the veterinary molecular diagnostics market are turning their attention to automating and scaling their diagnostic technologies, for example high-volume testing apparatus, in order to enhance diagnostic precision, amplify testing effectiveness, and facilitate the swift identification of animal diseases. High-volume testing apparatus are sophisticated diagnostic tools constructed to handle copious amounts of samples productively, allowing for swift and precise analyses in laboratory or clinical environments, especially beneficial for large-scale testing. As an illustration, in June 2023, the Veterinary Diagnostic Laboratory (VDL) at Iowa State University, a US institution, debuted the SmartChip, a ground-breaking molecular diagnostic test device furnished with quantitative polymerase chain reaction (qPCR) technology. This state-of-the-art device can hold more than 5,000 samples on a plate the size of a postage stamp. When paired with a system capable of handling 384 samples, furnished with automated features, this significantly augments its testing capacity. The SmartChip test uses microfluidic technology to recognize targets of interest in specimens, utilizing a volume that is 100 times smaller than the one utilized by VDL’s conventional 96-well machines.

View the full report here:

https://www.thebusinessresearchcompany.com/report/veterinary-molecular-diagnostics-global-market-report

What Are the Key Elements That Define the Veterinary Molecular Diagnostics Market?

Veterinary molecular diagnostics refers to using molecular biology techniques to identify and diagnose animal diseases at a genetic or molecular level. These tests detect the presence of specific pathogens (such as bacteria, viruses, or parasites), genetic mutations, or biomarkers that indicate disease, helping veterinarians make accurate diagnoses and treatment plans.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20687

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Drivers Are Shaping the Growth and Development of theVeterinary Molecular Diagnostics Market?

The surge in zoonotic diseases, diseases transferring from animals to humans, is anticipated to fuel the expansion of the veterinary molecular diagnostics market. The spread of these diseases, caused by various agents like bacteria, viruses, parasites, and fungi, is facilitated by numerous factors such as deforestation, exploitation of wildlife, intense animal agriculture, loss of biodiversity, and human movement. Rabies, Lyme disease, salmonellosis, toxoplasmosis, among others, are some usual zoonotic diseases. Early detection in animals through veterinary molecular diagnostics can prevent these diseases from reaching humans and promote better disease management by quickly and accurately identifying pathogens. To demonstrate, the Government of the United Kingdom released a report in February 2024 stating that confirmed cases of Lyme disease in England rose to 335 in the fourth quarter of 2023, a rise from 273 cases during the equivalent quarter in 2022. Consequently, the escalation in zoonotic diseases prevalence is stimulating the growth of the veterinary molecular diagnostics market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20687&type=smp

What is the Predicted Annual Growth Rate of theVeterinary Molecular Diagnostics Market Impact Industry Trends by 2034?

In recent times, the market size of veterinary molecular diagnostics has seen considerable growth. It is projected to expand from $0.63 billion in 2024 to $0.7 billion in 2025, experiencing a compound annual growth rate (CAGR) of 10.1%. Factors contributing to this growth during the historical period include a high occurrence of zoonotic and foodborne illnesses, an increase in the adoption of various testing panels, the ongoing consolidation of the veterinary diagnostics industry, a surge in spending on animal health, and a growing demand for food products derived from animals.

In the coming years, the market size for veterinary molecular diagnostics is projected to experience substantial growth, increasing to $1.01 billion by 2029 with a compound annual growth rate (CAGR) of 9.7%. The anticipated growth within this forecasted time frame can be credited to factors such as higher pet ownership, the surge in pet insurance uptake, growing pet population, rising expenditure on animal healthcare, and a surging demand for animal diagnostic tests. Prominent trends in this forecasted duration include the emergence of technological advancements in veterinary molecular diagnostic methods, development of advanced lab equipment, and the evolution of technologies like PCR, next-generation sequencing (NGS), and microarray.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20687

Which Cutting-Edge Market Trends Are Expected to Drive theVeterinary Molecular Diagnostics Market’s Growth?

Key players in the veterinary molecular diagnostics market are concentrating their efforts on incorporating automation and scalability into diagnostic technologies. This includes the development of high-volume testing devices that enhance diagnostic precision, boost testing efficiency, and expedite the identification of animal diseases. These high-capacity testing machines are innovative diagnostic instruments designed for efficient processing of massive amounts of samples, catering to rapid, precise analysis in laboratory or clinical environments, particularly important for large-scale testing. For example, in June 2023, the Veterinary Diagnostic Laboratory (VDL) at Iowa State University, a US-based institution, launched SmartChip. This is a state-of-the-art molecular diagnostic testing instrument furnished with quantitative polymerase chain reaction (qPCR) testing technology. This impressive device can house over 5,000 samples on a single plate, no larger than a standard postage stamp. With the combination of a 384-sample system equipped with automated handling features, SmartChip’s testing capacity is significantly boosted. SmartChip testing uses microfluidic technology to pinpoint targets of interest in samples, leveraging a volume 100 times smaller than the VDL’s usual 96-well machines.

What Are the Leading Market Players Impacting theVeterinary Molecular Diagnostics Market’s Growth Trend?

Major companies operating in the veterinary molecular diagnostics market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Zoetis Inc., Illumina Inc., PerkinElmer Inc., bioMérieux S.A., IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., LGC Group Ltd., Neogen Corporation, Abcam plc, Eiken Chemical Co. Ltd., Bioneer Corporation, INDICAL BIOSCIENCE GmbH, Biochek B.V., Ring Biotechnology Co. Ltd., Ingenetix GmbH, MiDOG Animal Diagnostics LLC, Biolab S.r.l., Bionote USA Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/veterinary-molecular-diagnostics-global-market-report

How Are the Key Segments of the Veterinary Molecular Diagnostics Market Driving Opportunities and Innovations?

The veterinary molecular diagnostics market covered in this report is segmented –

1) By Product: Kits And Reagents, Instrument

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Infectious Diseases, Genetic Diseases, Other Applications

4) By End-User: Diagnostic Laboratories, Veterinary Clinics, Veterinary Hospitals, Other End-Users

Subsegments:

1) Kits and Reagents: Polymerase Chain Reaction (PCR) Kits, Reverse Transcription PCR (RT-PCR) Kits, Real-Time PCR Kits, Nucleic Acid Extraction Kits, Enzyme-linked Immunosorbent Assay (ELISA) Kits, Hybridization Kits, Reagents for Next-Generation Sequencing (NGS)

2) Instruments: PCR Machines (Thermal Cyclers), Real-Time PCR Machines, Nucleic Acid Analyzers, Gel Electrophoresis Equipment, DNA Sequencers, Automated Liquid Handling Systems, Molecular Imaging Systems

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=20687&type=smp

What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theVeterinary Molecular Diagnostics Market?# Market Expansion?

North America was the largest region in the Veterinary Molecular Diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Veterinary Molecular Diagnostics Market 2025, By The Business Research Company:

Veterinary Diagnostic Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-diagnostic-equipment-global-market-report

Veterinary Vaccines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Veterinary Parasiticides Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-parasiticides-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the veterinary molecular diagnostics market size evolved in recent years?

In the past few years, the size of the veterinary molecular diagnostics market has shown quick expansion. Predictions state it will increase from $0.63 billion in 2024 to $0.7 billion in 2025, presenting a compound annual growth rate (CAGR) of 10.1%. Factors such as the widespread occurrence of zoonotic and foodborne illnesses, rising interest in numerous testing panels, consolidations in the veterinarian diagnostics sector, growing expenditure on animal healthcare, and the escalating requirement for food obtained from animals significantly contributed to growth during the historic period.

What are the predictions for the veterinary molecular diagnostics market size in the coming years?

In the imminent years, a significant increase in size is expected in the veterinary molecular diagnostics market, as it is projected to grow to a value of $1.01 billion in 2029, with a compound annual growth rate (CAGR) of 9.7%. This anticipated growth during the forecast period is due to factors such as increasing adoption of pets, rising pet insurance uptake, growing pet population, elevated animal healthcare spending, and burgeoning demand for animal diagnostic tests. Key trends predicted during the forecast period are advanced developments in veterinary molecular diagnostic technologies, sophisticated laboratory appliances, and innovations in techniques like PCR, next-generation sequencing (NGS), and breakthroughs in microarray technology.

Get your veterinary molecular diagnostics market report here!

https://www.thebusinessresearchcompany.com/report/veterinary-molecular-diagnostics-global-market-report

What key factors are fueling the growth of the veterinary molecular diagnostics market?

The rise in zoonotic diseases is expected to foster the expansion of the veterinary molecular diagnostics market. Zoonotic diseases, which are infections that spread between animals and humans, can originate from bacteria, viruses, parasites, or fungi. Examples of these diseases are rabies, Lyme disease, salmonellosis, and toxoplasmosis among others. Deforestation, wildlife exploitation, intensive animal farming, biodiversity loss, and human mobility are some factors that contribute to spreading zoonotic diseases. Veterinary molecular diagnostics are beneficial in early detection of these diseases in animals which helps prevent transmission to humans. Additionally, it aids in efficient disease control by swiftly and correctly identifying pathogens. For instance, as per a government report from the United Kingdom in February 2024, there was a rise in confirmed Lyme disease cases in England during the last quarter of 2023 with 335 cases reported, compared to 273 cases in the same period in 2022. Consequently, the increased occurrence of zoonotic diseases is fueling the growth of the veterinary molecular diagnostics market.

How is the global veterinary molecular diagnostics market divided into key segments?

The veterinary molecular diagnostics market covered in this report is segmented –

1) By Product: Kits And Reagents, Instrument

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Infectious Diseases, Genetic Diseases, Other Applications

4) By End-User: Diagnostic Laboratories, Veterinary Clinics, Veterinary Hospitals, Other End-Users

Subsegments:

1) Kits and Reagents: Polymerase Chain Reaction (PCR) Kits, Reverse Transcription PCR (RT-PCR) Kits, Real-Time PCR Kits, Nucleic Acid Extraction Kits, Enzyme-linked Immunosorbent Assay (ELISA) Kits, Hybridization Kits, Reagents for Next-Generation Sequencing (NGS)

2) Instruments: PCR Machines (Thermal Cyclers), Real-Time PCR Machines, Nucleic Acid Analyzers, Gel Electrophoresis Equipment, DNA Sequencers, Automated Liquid Handling Systems, Molecular Imaging Systems

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20687&type=smp

Who are the key firms paving the way for growth in the veterinary molecular diagnostics market?

Major companies operating in the veterinary molecular diagnostics market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Zoetis Inc., Illumina Inc., PerkinElmer Inc., bioMérieux S.A., IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., LGC Group Ltd., Neogen Corporation, Abcam plc, Eiken Chemical Co. Ltd., Bioneer Corporation, INDICAL BIOSCIENCE GmbH, Biochek B.V., Ring Biotechnology Co. Ltd., Ingenetix GmbH, MiDOG Animal Diagnostics LLC, Biolab S.r.l., Bionote USA Inc.

Which trends are expected to transform the veterinary molecular diagnostics market?

Prominent enterprises involved in the veterinary molecular diagnostics market are shifting their focus towards the automation and scaling of diagnostic methods, such as high-throughput testing devices. This shift aims to enhance diagnostic accuracy, facilitate efficient testing, and expedite the detection of diseases in animals. High-throughput testing machines, sophisticated diagnostic tools capable of efficiently analyzing a large number of samples, are ideal for broad-scale testing in labs or clinic environments. To illustrate, in June 2023, Iowa State University’s Veterinary Diagnostic Laboratory (VDL), a U.S.-based institution, launched an avant-garde molecular diagnostic testing device named SmartChip, equipped with quantitative polymerase chain reaction (qPCR) testing technology. Remarkably, this ground-breaking gadget can handle over 5,000 samples on a plate barely larger than a postage stamp and has a significantly expanded testing capacity when teamed up with a 384-sample system with automated handling features. SmartChip testing employs microfluidic technology to isolate specific interest targets in samples, using a volume 100 times smaller than that used by VDL’s conventional 96-well machines.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20687

What regions are contributing significantly to the growth of the veterinary molecular diagnostics market?

North America was the largest region in the Veterinary Molecular Diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Veterinary Diagnostic Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-diagnostic-equipment-global-market-report

Veterinary Vaccines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Veterinary Parasiticides Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-parasiticides-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Projected Compound Annual Growth Rate (CAGR) of the Veterinary Molecular Diagnostics Market from 2025 to 2034, and What Factors Influence It?

In recent times, the veterinary molecular diagnostics market has been expanding swiftly. It is projected to increase from $0.63 billion in 2024 to $0.7 billion in 2025, with a compound annual growth rate (CAGR) of 10.1%. The historic trend of growth is largely due to the widespread occurrence of zoonotic and foodborne diseases, the increase in adoption of multiple diagnostic tests, the growing consolidation in the veterinary diagnostic sector, an increase in animal health expenditure, and the escalating demand for food obtained from animals.

The market for veterinary molecular diagnostics is anticipated to witness considerable expansion in the coming years, surging to a worth of $1.01 billion by 2029 with a compound annual growth rate (CAGR) of 9.7%. Factors contributing to this projected growth include a surge in the ownership of pets, an increase in the uptake of pet insurance, a growing pet population, a rise in spending on animal health care, and heightened need for animal diagnostic tests. The anticipated trends during this forecast period encompass advancements in veterinary molecular diagnostic technologies, state-of-the-art laboratory devices, and enhanced technology such as Polymerase Chain Reaction (PCR), next-generation sequencing (NGS), and microarray technological advancements.

What Combination of Drivers Is Leading to Accelerated Growth in the Veterinary Molecular Diagnostics Market?

The veterinary molecular diagnostics market’s expansion is anticipated to be fueled by the high occurrence of zoonotic diseases. Zoonotic diseases, which are infections transmitted between animals and humans, can be caused by bacteria, viruses, parasites, or fungi. Some commonly known zoonotic diseases are rabies, Lyme disease, salmonellosis, and toxoplasmosis. Factors like deforestation, wildlife exploitation, intensive animal farming, biodiversity loss, and human mobility influence the prevalence of these diseases. Through early detection of zoonotic diseases in animals, veterinary molecular diagnostics can effectively prevent their transmission to humans. Moreover, they facilitate disease control by allowing swift and precise identification of pathogens. For example, a report released by the UK Government in February 2024 indicated that there were 335 confirmed cases of Lyme disease in England during the fourth quarter of 2023, up from 273 in the corresponding period in 2022. Consequently, the escalating occurrence of zoonotic diseases is propelling the growth of the veterinary molecular diagnostics market.

Explore Comprehensive Insights Into The Global Veterinary Molecular Diagnostics Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20687&type=smp

Who Are the Leading Players Fueling Growth in the Veterinary Molecular Diagnostics Market?

Major companies operating in the veterinary molecular diagnostics market are:

• Roche Diagnostics Corporation

• Thermo Fisher Scientific Inc.

• Merck KGaA

• Zoetis Inc.

• Illumina Inc.

What Are the Emerging Trends Shaping the Future of the Veterinary Molecular Diagnostics Market?

Leading firms in the veterinary molecular diagnostics market are prioritizing automation and scalability in diagnostic technologies, including high-volume testing devices. These advancements are aimed at enhancing diagnostic precision, boosting testing efficiency, and facilitating prompt disease identification in animals. High-volume testing machines, developed diagnostic tools capable of handling substantial amounts of samples effectively, are especially suitable for large-scale testing due to their speedy and accurate laboratory or clinical analysis. For example, the Veterinary Diagnostic Laboratory (VDL) from the US-based Iowa State University, launched SmartChip in June 2023. It is a state-of-the-art molecular diagnostic test device featuring quantitative polymerase chain reaction (qPCR) testing technology. This groundbreaking device can hold more than 5,000 samples on a plate no larger than a postage stamp and increases its testing capacity manifold when combined with a system capable of handling 384 samples automatically. The SmartChip test uses microfluidic technology to detect targets of interest in samples using a volume that’s 100 times smaller than what is used in VDL’s traditional 96-well machines.

Get Instant Access to the Global Veterinary Molecular Diagnostics Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/veterinary-molecular-diagnostics-global-market-report

Which Segments Play a Crucial Role in the Expansion of the Veterinary Molecular Diagnostics Market?

The veterinary molecular diagnostics market covered in this report is segmented –

1) By Product: Kits And Reagents, Instrument

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Infectious Diseases, Genetic Diseases, Other Applications

4) By End-User: Diagnostic Laboratories, Veterinary Clinics, Veterinary Hospitals, Other End-Users

Subsegments:

1) Kits and Reagents: Polymerase Chain Reaction (PCR) Kits, Reverse Transcription PCR (RT-PCR) Kits, Real-Time PCR Kits, Nucleic Acid Extraction Kits, Enzyme-linked Immunosorbent Assay (ELISA) Kits, Hybridization Kits, Reagents for Next-Generation Sequencing (NGS)

2) Instruments: PCR Machines (Thermal Cyclers), Real-Time PCR Machines, Nucleic Acid Analyzers, Gel Electrophoresis Equipment, DNA Sequencers, Automated Liquid Handling Systems, Molecular Imaging Systems

Which Regions Are Driving Growth in the Veterinary Molecular Diagnostics Market?

North America was the largest region in the Veterinary Molecular Diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Defining Features of the Veterinary Molecular Diagnostics Market?

Veterinary molecular diagnostics refers to using molecular biology techniques to identify and diagnose animal diseases at a genetic or molecular level. These tests detect the presence of specific pathogens (such as bacteria, viruses, or parasites), genetic mutations, or biomarkers that indicate disease, helping veterinarians make accurate diagnoses and treatment plans.

Browse Through More Similar Reports By The Business Research Company:

Veterinary Diagnostic Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-diagnostic-equipment-global-market-report

Veterinary Vaccines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Veterinary Parasiticides Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-parasiticides-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: